{"log_id": 4517637204048172703, "direction": 0, "words_result_num": 45, "words_result": [{"probability": {"variance": 0.003232, "average": 0.982103, "min": 0.627208}, "location": {"width": 849, "top": 118, "height": 41, "left": 185}, "words": "在布托啡诺的人体研究中,通常在0.5mg或更高的剂量下具有镇静作用。静脉注射10-~12mg的布托"}, {"probability": {"variance": 1e-05, "average": 0.997791, "min": 0.987678}, "location": {"width": 320, "top": 160, "height": 32, "left": 147}, "words": "啡诺10~15分钟后可产生了麻醉作用"}, {"probability": {"variance": 0.003506, "average": 0.985904, "min": 0.607973}, "location": {"width": 852, "top": 185, "height": 40, "left": 185}, "words": "像对k-受体具有高度亲和性的其他混合激动拮抗剂一样,布托啡诺在一些人体中可能产生了令人不"}, {"probability": {"variance": 2e-06, "average": 0.997776, "min": 0.995404}, "location": {"width": 141, "top": 231, "height": 25, "left": 146}, "words": "快的致幻觉作用"}, {"probability": {"variance": 0.002223, "average": 0.983553, "min": 0.772751}, "location": {"width": 519, "top": 256, "height": 35, "left": 186}, "words": "通过任何途径使用1mg或更高剂量可能会引起恶心和/或呕吐"}, {"probability": {"variance": 2.3e-05, "average": 0.998154, "min": 0.970445}, "location": {"width": 856, "top": 286, "height": 36, "left": 187}, "words": "在没有严重呼吸功能障碍的受试者中进行的人体研究中,静脉注射2mg的布托啡诺和静脉注射10mg"}, {"probability": {"variance": 0.000709, "average": 0.993946, "min": 0.823744}, "location": {"width": 883, "top": 317, "height": 38, "left": 151}, "words": "的硫酸吗啡对呼吸的抑制作用相当。在更高剂量下,布托啡诺对呼吸的抑制作用强度并没有增大;然而"}, {"probability": {"variance": 0.001337, "average": 0.992421, "min": 0.750339}, "location": {"width": 894, "top": 349, "height": 39, "left": 149}, "words": "抑制呼吸的持续时间延长了。使用纳洛酮这种特殊阿片类拮抗剂可以逆转通过任何途径使用布托啡诺后发"}, {"probability": {"variance": 1e-06, "average": 0.999306, "min": 0.998135}, "location": {"width": 158, "top": 392, "height": 26, "left": 151}, "words": "现的呼吸抑制作用"}, {"probability": {"variance": 3e-06, "average": 0.998845, "min": 0.99218}, "location": {"width": 631, "top": 416, "height": 35, "left": 188}, "words": "酒石酸布托啡诺在动物体内在低于产生镇痛作用的剂量下产生了镇咳作用"}, {"probability": {"variance": 7.6e-05, "average": 0.996431, "min": 0.948149}, "location": {"width": 853, "top": 444, "height": 41, "left": 189}, "words": "心脏插管患者静脉单剂量注射0.025mg/kg布托啡诺时出现血液动力学变化,包括肺动脉压、肺动脉"}, {"probability": {"variance": 5.5e-05, "average": 0.996934, "min": 0.965893}, "location": {"width": 554, "top": 483, "height": 33, "left": 150}, "words": "楔压和血管阻力的增大,左心室舒张末期压和全身动脉压的增大"}, {"probability": {"variance": 1e-06, "average": 0.998826, "min": 0.997848}, "location": {"width": 61, "top": 529, "height": 24, "left": 152}, "words": "药效学"}, {"probability": {"variance": 0.007935, "average": 0.982441, "min": 0.408448}, "location": {"width": 841, "top": 543, "height": 37, "left": 201}, "words": "托啡诺的镇痛作用受给药途径的影响。镇痛作用在静脉注射几分钟后产生,在肌肉注射15分钟内"}, {"probability": {"variance": 0, "average": 0.999429, "min": 0.99891}, "location": {"width": 41, "top": 588, "height": 23, "left": 152}, "words": "产生"}, {"probability": {"variance": 0.000304, "average": 0.994407, "min": 0.914962}, "location": {"width": 438, "top": 611, "height": 33, "left": 190}, "words": "静脉和肌肉注射后30~60分钟内达到最大镇痛作用"}, {"probability": {"variance": 0.00375, "average": 0.9874, "min": 0.583301}, "location": {"width": 849, "top": 637, "height": 38, "left": 192}, "words": "镇痛作用的持续时间随疼痛模型和给药途径而改变,但肌肉注射和静脉注射给药后一般3m4小时50"}, {"probability": {"variance": 0.000166, "average": 0.995433, "min": 0.921831}, "location": {"width": 894, "top": 669, "height": 37, "left": 153}, "words": "的患者需要再次给药。在术后研究中,当以相同的给药方式使用等效剂量时,静脉注射或肌肉注射布托啡"}, {"probability": {"variance": 0.010069, "average": 0.970801, "min": 0.50086}, "location": {"width": 473, "top": 705, "height": 32, "left": 155}, "words": "诺的镇痛持续时间与吗啡、哌替啶和喷他佐辛是相似的"}, {"probability": {"variance": 2e-06, "average": 0.998614, "min": 0.995457}, "location": {"width": 259, "top": 740, "height": 30, "left": 153}, "words": "致癌性、致突变、生育力损伤"}, {"probability": {"variance": 0.004702, "average": 0.976402, "min": 0.546679}, "location": {"width": 851, "top": 762, "height": 39, "left": 193}, "words": "小鼠和大鼠随饮食给予布托啡诺60mg/ kg/day(小鼠180mg/m2:大鼠354mg/m2)进行为期2年的致癌"}, {"probability": {"variance": 1.1e-05, "average": 0.998748, "min": 0.98494}, "location": {"width": 397, "top": 801, "height": 31, "left": 155}, "words": "性研究。研究显示本品对小鼠大鼠均无致癌性"}, {"probability": {"variance": 0.001044, "average": 0.994392, "min": 0.78262}, "location": {"width": 853, "top": 825, "height": 37, "left": 194}, "words": "鼠伤寒沙门氏菌、大肠杆菌试验或人源成纤维细胞非程序DNA合成和修复试验显示布托啡诺无遗传"}, {"probability": {"variance": 0, "average": 0.999361, "min": 0.99877}, "location": {"width": 41, "top": 871, "height": 22, "left": 157}, "words": "毒性"}, {"probability": {"variance": 0.004284, "average": 0.968069, "min": 0.654123}, "location": {"width": 818, "top": 889, "height": 38, "left": 195}, "words": "大鼠口服布托啡诺160 mg/kg/day(944mg/m2)可降低妊娠率。然而,皮下给予2.5mgkg/day(14.75"}, {"probability": {"variance": 0.011234, "average": 0.964414, "min": 0.560748}, "location": {"width": 254, "top": 926, "height": 35, "left": 159}, "words": "mg/m2)布托啡诺没有类似作用"}, {"probability": {"variance": 4e-06, "average": 0.998117, "min": 0.993526}, "location": {"width": 122, "top": 968, "height": 24, "left": 166}, "words": "【药代动力学】"}, {"probability": {"variance": 0.005196, "average": 0.976526, "min": 0.725645}, "location": {"width": 453, "top": 987, "height": 33, "left": 197}, "words": "本品肌注后很快吸收,在20-40分钟达到血浆峰浓度"}, {"probability": {"variance": 0.009153, "average": 0.979922, "min": 0.369545}, "location": {"width": 853, "top": 1013, "height": 38, "left": 195}, "words": "经过初始的吸收分布阶段后,布托啡诺单次静脉注射与肌肉注射的药代动力学相似。在不大于7ng/ml"}, {"probability": {"variance": 0.000331, "average": 0.992029, "min": 0.91317}, "location": {"width": 893, "top": 1045, "height": 38, "left": 157}, "words": "的浓度范围内血清蛋白结合与浓度无关,结合率约为80%。布托啡诺的表观分布容积为309~901L,总体"}, {"probability": {"variance": 0.001544, "average": 0.988579, "min": 0.754404}, "location": {"width": 678, "top": 1079, "height": 36, "left": 157}, "words": "清除率为52~154L/小时。本品可通过血脑屏障和胎盘屏障,可进入人的乳汁中"}, {"probability": {"variance": 1e-05, "average": 0.998133, "min": 0.981779}, "location": {"width": 854, "top": 1108, "height": 38, "left": 199}, "words": "布托啡诺主要在肝脏被代谢,静脉注射、肌肉注射给药后的代谢物相似。由于布托啡诺广泛的首过代"}, {"probability": {"variance": 0.003506, "average": 0.982989, "min": 0.642953}, "location": {"width": 770, "top": 1142, "height": 37, "left": 159}, "words": "谢,口服生物利用度只有5~17%。主要代谢产物为羟基化布托啡诺,同时也产生少量的no"}, {"probability": {"variance": 2e-06, "average": 0.999077, "min": 0.992664}, "location": {"width": 564, "top": 1177, "height": 33, "left": 161}, "words": "使用布托啡诺后在血浆中检测到了这两种物质,在大部分的时间点"}, {"probability": {"variance": 0.00094, "average": 0.984903, "min": 0.89393}, "location": {"width": 214, "top": 1174, "height": 24, "left": 838}, "words": "ol只是微量级水平。羟基"}, {"probability": {"variance": 0.000144, "average": 0.994537, "min": 0.934059}, "location": {"width": 890, "top": 1205, "height": 37, "left": 159}, "words": "布托啡诺的消除半衰期大约是18小时,因此,当给与布托啡诺直至稳态(每6小时给药1mg,给药5天"}, {"probability": {"variance": 0.000523, "average": 0.990588, "min": 0.900697}, "location": {"width": 319, "top": 1244, "height": 30, "left": 159}, "words": "时会出现相当大的蓄积(大约是5倍)"}, {"probability": {"variance": 0.002593, "average": 0.985049, "min": 0.71289}, "location": {"width": 854, "top": 1267, "height": 38, "left": 199}, "words": "该药通过尿液和粪便排泄进行消除。当健康受试者使用3H标记的布托啡诺时,在尿液中发现了大部"}, {"probability": {"variance": 0.000432, "average": 0.992935, "min": 0.8683}, "location": {"width": 892, "top": 1298, "height": 41, "left": 161}, "words": "分(70~80%)的剂量,而在粪便中发现了大约15%。在尿液中发现的大约5%的剂量是布托啡诺,49%为羟"}, {"probability": {"variance": 0, "average": 0.999755, "min": 0.999207}, "location": {"width": 100, "top": 1345, "height": 24, "left": 162}, "words": "基布托啡诺"}, {"probability": {"variance": 0.000155, "average": 0.991581, "min": 0.966751}, "location": {"width": 132, "top": 1342, "height": 24, "left": 343}, "words": " phanom不到5%"}, {"probability": {"variance": 0.003901, "average": 0.98563, "min": 0.59838}, "location": {"width": 853, "top": 1364, "height": 39, "left": 201}, "words": "老年受试者中的布托啡诺药代动力学与年轻患者不同。老年患者的清除半衰期增加(为6.6小时,而年"}, {"probability": {"variance": 0.001814, "average": 0.985804, "min": 0.851115}, "location": {"width": 185, "top": 1409, "height": 26, "left": 162}, "words": "轻受试者为4.7小时)"}, {"probability": {"variance": 0.007352, "average": 0.971712, "min": 0.601219}, "location": {"width": 854, "top": 1429, "height": 38, "left": 202}, "words": "肌酐清除率<30毫升/分钟的肾功能障碍者,半衰期延长:约为10.5小时(健康受试者为5.8小时)机"}, {"probability": {"variance": 0.012014, "average": 0.960722, "min": 0.451616}, "location": {"width": 367, "top": 1466, "height": 34, "left": 165}, "words": "体总清除率为150L/h(健康受试者为260L/h"}], "language": 3}